The detection of chimeric transcripts derived 
INTRODUCTION
The detection of leukemic specific fusion transcripts by RT-PCR has revolutionized the field of molecular diagnosis. Since the initial discovery of the fusion between the BCRand ABL genes in t(9;22) (3), many other medically relevant chromosome abnormalities have been identified that result in the juxtaposition and fusion of gene sequences. The fused genes involved in these chromosome aberrations that lead to leukemia play a major role in the development and function of cells from the myeloid and lymphoid lineages. Many studies have shown that the identification of chromosome aberrations are useful for risk group classification such as t (9;22) and 11q23 aberrations that are associated with a poor prognosis (12, 15) . Conversely, t(12;21) in pediatric acute lymphoblastic leukemia (ALL) and t(8;21), t (15;17) , inv (16) involved in acute myeloid leukemia (AML) are associated with a good prognosis (6, 16) . Moreover, the detection of remaining leukemic cells (minimal residual disease, MRD) during and after medical treatment has been shown to provide a valuable tool with prognostic relevance (2, 4, 11) .
The most sensitive techniques are based on the analysis of specific fusion genes by conventional RT-PCR using oligonucleotide primers spanning the breakpoint region. After gel electrophoresis, the amount of PCR product is determined by comparison with serial 10-fold step dilutions of leukemic cells or RNA in a semi-quantitative manner. One of the first quantification methods was competitive PCR (2), but this technique is difficult, prone to error, and time-consuming. Advances in quantitative strategies include real-time PCR (7) , where the amount of PCR product is quantified following each cycle of the reaction. Real-time PCR is known to be a sensitive method to detect DNA products, ensures detection during the linear range of amplification, and eliminates the need for post-PCR analysis. This technique is now increasingly used for MRD detection but unfortunately requires very expensive instrumentation and reagents.
Our goal was to develop a simple, inexpensive, reproducible, and automated method to quantify RT-PCR products. This new approach incorporates a multiplex fluorescent PCR method (10) in conjunction with direct analysis of the PCR products using a laser-induced fluorescence capillary electrophoresis system, the ABI P RISM ® 310A (Applied Biosystems, Foster City, CA, USA). Five different leukemia cell lines availMolecular Diagnostic Techniques able in our laboratory were used to validate our novel technique. The criteria used to evaluate this method included sensitivity, linearity, and reproducibility.
MATERIALSANDMETHODS

Cell Lines
The 
RNA Preparation
Total RNAs of cell lines were prepared by TRI ZOL ® extraction (Invitrogen, Cergy Pontoise, France). Cells (1 × 10 7 ) were homogenized in 1 mL TRI ZOL reagent, 0.2 mL chloroform were added, and after 5 min at room temperature, the tubes were centrifuged at 1 2 000 ×gfor 15 min at 4°C. The soluble RNA in the aqueous phase was then precipitated in an equal volume of isopropanol. After washing in 75% ethanol, RNAs were resuspended in 30 µ L RNase-free water and stored at -80°C. The amount of extracted RNA was determined by measuring absorbance at 260 nm.
Serial dilutions of each cell line were prepared once for all tests presented in this study and stored at -80°C. Each cell line RNA was diluted into normal RNA in 10-fold steps from undiluted to 10 -6 . Normal RNA used for the dilution experiments was obtained from phlebotomy of patients followed for hemochromatosis and was confirmed as negative for all the specific transcripts explored in this study.
cDNA Synthesis
One microgram of RNA (undiluted or diluted) was preliminarily denatured in a 10-µ L partial reaction at 70°C for 10 min and used for the synthesis of cDNA in a 25-µ L total reaction containing 0.25 µ g random hexamers, 200 U Moloney murine leukemia virus (MMLV) reverse transcriptase (Invitrogen), and 20 U RNasin ® (Promega, Charbonnières, France). RT reactions were performed at 23°C for 10 min, followed by 42°C for 45 min and 99°C for 3 min. Negative controls without reverse transcriptases were made for each RNA preparation. Aliquots of cDNA were stored at -20°C before use. Table 1 shows the primers used in multiplex RT-PCR analysis. The hypoxanthine phosphoribosyltransferase ( HPRT ) housekeeping gene (13) was co-amplified as an internal control. HPRT-F and HPRT-R were incorporated in each mixture to amplify a fragment of 213 bp. To avoid competitive co-amplification, the HPRT primers were added at a lower concentration (0.075 µ M) in all mixtures. One primer of each pair was 5 ′ end-labeled: HEX-labeled (green) for chimeric gene products (Table 1) and NED-labeled (dark) for HPRT-F. After amplification, we added 2 µ L each PCR to 17.5 µ L deionized formamide and 0.5 µ L ROX-labeled (red) Genescan-400 ® size-standards (GS400HD; Applied Biosystems). After heating for 5 min at 95°C and rapidly chilling on ice, samples were automatically loaded onto the ABI P RISM310A laser-induced fluorescence capillary electrophoresis system, according to the manufacturer's instructions. Amplified fragment sizes and peak height values were determined after treatment by Genescan software (Applied Biosystems). Co-amplification results were expressed as the ratio between the chimeric PCR product and the HPRT internal control PCR product (gene: HPRTratio). Some amplification products performed by fluorescent PCR were checked by electrophoresis on a nondenaturing 8% acrylamide gel. Expected sizes for each specific transcript were found following hybridization with a biotinylated end-labeled specific probe (data not shown).
The co-amplification efficiencies were determined for each specific fusion transcript using cDNA obtained from each cell line. Multiplex fluorescent PCRs were performed in different rounds (22, 24, 26, 28, 30, 32, and 35 cycles) with HPRT as the reference gene. In this way, the optimal PCR cycle number could be evaluated to determine the definitive conditions of our method.
In the final protocol, the five different cell line serial dilutions were analyzed in duplicate. A standard curve was established for each cell line by plotting the gene: HPRTratio versus the known RNA dilution on a logarithm scale. The relative quantity of fusion gene transcript in unknown samples could be calculated automatically by reference to this curve.
RESULTS AND DISCUSSION
Recent technological advances in strategies to quantify PCR products include very expensive methods. We present here a simple method to quantify RT-PCR products based on a fluorescent PCR methodology. In this study, we performed a specific, reproducible, and sensitive method to quantify specific fusion transcripts in leukemic patients to follow the MRD. Using our multiplex fluorescent PCR method, we detected specific amplification products with the expected sizes following analysis using Genescan software, according to the design of the selected primers (references in Table 1 ).
The reproducibility of the 310A apparatus was evaluated by loading 10 aliquots from one RT-PCR and the CV between peak heights or peak height ratios was found to be less than 5% (13) . The intra-assay reproducibility showed only minimal variation of the gene: HPRT ratio. The inter-assay reproducibility was evaluated on two different sets of PCR and showed variations less than 10% using the peak height ratio. The independent housekeeping gene HPRT has been selected in this study because it is moderately expressed in mammal cells compared with other housekeeping genes (5) . The use of the HPRTgene as an internal PCR control in our method was an excellent way to eliminate false-negative results and in conditions that avoided competitive coamplification. We have evaluated the PCR product yield for each target chimeric transcript and compared them to the HPRT transcripts using cDNA from each cell line. PCR co-amplification efficiencies were determined at different PCR rounds (22-35 cycles) to evaluate optimal conditions (Figure 1 ). The PCR co-amplification ratio showed lower variation in the later part of the exponential amplification phase. This assumes that any preferential amplification of one cDNA did not occur between the chimeric cDNA and the HPRT cDNA. These results demonstrate that the gene: HPRTratios were most constant between 30 and 32 amplification cycles. All subsequent analyses were thus performed in this range of PCR co-amplification efficiencies.
It is worth noting that expression levels of HPRTin the five cell lines are not very different. This is demonstrated in Figure 2 , where we have brought together the peak height values of HPRT PCR products obtained in the experiments presented in Figure 1 . Only with REH and 697 cell lines the expression of HPRTis slightly lower than the values of the others.
One of the advantages of our method is that we could quantify together the two co-amplified products from the same loading. In this way, the internal control was analyzed at the same time and the ratio gene: HPRTallowed us to normalize the possible variable steps from RNA extraction to PCR.
The standard curves presented in Figure 3 showed that quantification of each target transcript was linear on a 
